| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 783.30M | — |
| Operating expense | — | — |
| Net income | 333.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, UTH.F returned +63.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +2.4% |
| 1 year | +63.3% |
| 5 years | +144.2% |
| 10 years | +301.0% |
| All-time high | €509.80 (Mar 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in UTH.F would be worth today ›No. United Therapeutics Corporation has not paid a dividend in the past 12 months.
United Therapeutics Corporation is part of the Healthcare sector.
United Therapeutics Corporation has a market cap of 18.75B EUR, based on the latest quote.
United Therapeutics Corporation is expected to report earnings around Oct 28, 2026. That date is an estimate and has not been confirmed by the company.
